Plain-English translation of NCT06600698 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Prostate Cancer research guide โPhase 1/2 โ A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a herbal supplement called AGN- to see if it can help men with prostate cancer whose PSA levels (a marker measured in blood) are rising after treatment. The trial has two stages: first, researchers will figure out the safest and best dose of this medication, and then they'll test whether it actually works to stabilize or lower PSA levels in patients who have had prostate surgery or radiation therapy.
Men who have been treated for prostate cancer sometimes experience rising PSA levels, which can signal that cancer cells are returning. There is a need for new treatment options to help control or slow this rise, and this medication may offer a gentler alternative to standard treatments.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, you will take the medication by mouth every day. In the first stage, researchers will start with a low dose and gradually increase it in small groups to find the safest dose. In the second stage, you will take the medication at that safe dose for about 6 months (six treatment cycles). You will have regular clinic visits to have blood tests, answer questions about side effects, and have your PSA levels checked to see if the medication is working.
AI-generated summary from trial data ยท Sep 2, 2026 ยท Not medical advice
United States